Press release
Wilms Tumor Protein Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027
The global wilms tumor protein market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Wilms' tumor protein is a protein that is encoded by the WT1 gene on chromosome 11p in humans. The major factor driving the demand for the global Wilms tumor protein market during the forecast period is the increasing prevalence of leukemia across the globe. According to the Leukemia & Lymphoma Society, one person is diagnosed with leukemia approximately every 3 minutes in the US. Additionally, in 2021, an estimated combined total of 186,400 people are anticipated to be diagnosed with leukemia, lymphoma or myeloma in the US.Furthermore, in 2021, new cases of leukemia, lymphoma and myeloma are anticipated to account for 9.8% of the estimated 1,898,160 new cancer cases. Moreover, an estimated 1,519,907 people are living with or in remission from leukemia, lymphoma, myeloma in the US. Apart from this, WT1 plays an important role in cell growth and differentiation and is highly expressed in leukemia and act as a tumor marker to detect minimal residual disease of leukemia. Hence, the increasing prevalence of leukemia is driving the demand for Wilms tumor proteins which in turn is driving the growth of the market.
To Request a Sample of our Report on Wilms Tumor Protein Market: https://www.omrglobal.com/request-sample/wilms-tumor-protein-market
Some major players in the market include SELLAS Life Sciences Group Inc., and Sumitomo Dainippon Pharma Co., Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2020, Sumitomo Dainippon Pharma Oncology, Inc., announced the dosing of the first patient with DSP-7888 in the Phase 2 expansion portion of the study evaluating the vaccine. DSP-7888 is an investigational immunotherapeutic cancer vaccine that targets WT1 in combination with checkpoint inhibitor pembrolizumab in patients with platinum-resistant ovarian cancer (PROC).
Market Coverage
· The market number available for - 2020-2027
· Base year- 2020
· Forecast period- 2021-2027
Segment Covered-
· By Type
· By Application
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape- SELLAS Life Sciences Group Inc., and Sumitomo Dainippon Pharma Co., Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Wilms Tumor Protein Market is Available @ https://www.omrglobal.com/industry-reports/wilms-tumor-protein-market
Global Wilms Tumor Protein Market Report by Segment
By Type
· Elatipepimut-S
· Galinpepimut-S
· GSK-2130579A
· INO-5401
· OCV-501
· Others
By Application
• Adrenal Gland Cancer
• High-Grade Glioma
• Lung Cancer
• Peritoneal Cancer
• Leukemia
• Others
Global Wilms Tumor Protein Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Wilms Tumor Protein Market Share 2021 Growth Challenges, Opportunities and Future Trends 2027 here
News-ID: 2576931 • Views: …
More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033.
AI-Enabled Imaging Modalities Market Overview
The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including…

Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of…

Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033.
Tumor Tracking Systems Market Overview
The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the…

SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034.
SNP genotyping Market Overview
The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This…
More Releases for Wilms
Wilms Tumor Market Emerging Trends and Growth Prospects 2034
Introduction
Wilms tumor, or nephroblastoma, is a rare pediatric kidney cancer that typically affects children under the age of 5. Representing nearly 6% of all childhood cancers, Wilms tumor is one of the most treatable pediatric malignancies when diagnosed early. Advances in multimodal treatment approaches - surgery, chemotherapy, and radiotherapy - combined with emerging targeted therapies and genetic insights have significantly improved survival rates.
The global Wilms Tumor Market is gaining momentum…
Rising Incidence Of Kidney Cancers Drives Growth In The Wilms Tumor Protein Mark …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Wilms Tumor Protein Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size for the Wilms tumor protein has been experiencing consistent growth. It is projected to increase from $3.27 billion in 2024 to an estimated $3.42 billion in 2025, with…
Key Trend Reshaping the Wilms Tumor Protein Market in 2025: Innovative Detection …
What Are the Projections for the Size and Growth Rate of the Wilms Tumor Protein Market?
In the past few years, the wilms tumor protein market size has seen consistent growth. It is anticipated that it will increase from $3.27 billion in 2024 to $3.42 billion in 2025, with a compound annual growth rate (CAGR) of 4.7%. The growth during the historical period can be associated with the incidence and diagnosis…
Wilms Tumor Treatment Market Analysis, Share, Trends, and Overview 2024-2031
The global Wilms tumor treatment market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Wilms tumor is a kind of kidney cancer that most commonly affects children. 'Nephroblastoma' is the name given to Wilms tumor. It usually affects youngsters between the ages of 3 and 4, however, in rare circumstances, it has been found in children as young as 5 years old. After the age…
Wilms Tumor Protein Market Analysis 2024: Global Opportunities and Future Projec …
"The Business Research Company recently released a comprehensive report on the Global Wilms Tumor Protein Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The wilms tumor…
Understanding Wilms Tumor Protein Market 2024
The wilms tumor protein market size has grown strongly in recent years. It will grow from $3.09 billion in 2023 to $3.27 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to cancer incidence and diagnosis, rising awareness and screening programs, collaborations in cancer care..
The wilms tumor protein market size is expected to see strong growth…